NIDA editorial supports use of buprenorphine implant for opioid use disorder

Courtesy of Braeburn Pharmaceuticals

An editorial published today in The Journal of the American Medical Association by NIDA Director Dr. Nora Volkow and NIDA Deputy Director Dr. Wilson Compton discusses the importance of the new long-acting buprenorphine implant technology as an added tool in…

Go to Source

Powered by WPeMatico